N.I.H. May Fund Human-Animal Stem Cell Research

The National Institutes of Health announced on Thursday that it was planning to lift its ban on funding some research that injects human stem cells into animal embryos. The N.I.H. announced its proposal in a blog post by Carrie Wolinetz, the associate director for science policy, and in the Federal Register. The purpose is to

Stem cell research in the US: More money to/from state initiatives?

The  California Institute for Regenerative Medicine (CIRM), a state agency with a US$3-billion budget for stem-cell research, is in need of more funding. Nature reports that “CIRM had to revamp its structure and practices in response to complaints about inefficiency and potential conflicts of interest. It has also had to adapt its mission to seismic

Abnormalities in human pluripotent cells due to reprogramming mechanisms

Researchers from Oregon Health & Science University show that, when pluripotent stem cells (iPSCs) or stem cells created using a process called somatic cell nuclear transfer (SCNT) are compared, the genomic and epigenomic landscapes of the resulting cell types differ with the genomes of stem cells created through SCNT matching those of embryonic stem cells

Jordan adopted new stem-cell law

In January, Jordan passed a law to control research and therapy using human stem cells derived from embryos — the first such regulation in the Arab and Islamic region. Rana Dajani, who is associate professor of molecular cell biology at the Hashemite University in Zarqa, Jordan, and was part of the legislative initiative, writes Jordan has become

US Stem Cell Company Heads to Mexico After FDA Reprimand

The attack on stem cell research has driven at least one regenerative medicine company to seek friendlier climes south of the border. Six months after the federal government forced it to stop its treatments, the Houston-based Celltex Therapeutics moved its operations to Mexico to avoid the long arm of the law. The U.S. Food and

A closer look at stem cell frauds is needed

I have recently been forwarded an article by Arthur Caplan, director of the Center for Bioethics at the University of Pennsylvania, commenting the negative effects of fraudulent uses of stem cells: “Stem cell clinics ripping off patients, bullying scientists” http://www.msnbc.msn.com/id/43760409/ns/health-health_care/. No news, I said, since Luca Coscioni Association, who has been advocating for the promotion